Sequel’s twiist will become the first automated insulin delivery system to integrate with Senseonics' one-year CGM system.

Medtronic expanded its Touch Surgery Ecosystem (TSE) in April 2024 by launching the Live Stream function in the training app.

Metrion has launched the NaV1.9 screening assay, aimed at progressing the discovery along with the development of new pain ...

The US FDA has granted breakthrough device designation to Roche's companion diagnostic VENTANA TROP2 (EPR20043) RxDx Device.

The letter acknowledged the potential of brain-computer interface technology yet noted that neurotech collects brain data ...

Gestalt Diagnostics has completed a Series A financing round, raising $7.5m for expanding its AI-powered PathFlow pathology ...

J&J submitted a New Drug Application to the FDA for TAR-200 in January 2025 following positive data from the SunRISe-1 trial.

A new paper evaluating Neuromod’s tinnitus treatment has found that 91.5% of patients saw reductions after 12 weeks of ...

Zenflow has reported that its Spring System demonstrated durable benefits three years post-placement for individuals with BPH ...

Abbott has reported new data from its Volt CE Mark Study in individuals treated with PFA therapy using the Volt PFA System ...

The US FDA has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for insertion in the right ...

CEO Gary Guthart quelled concerns of reflexive pricing, with production and manufacturing optimisation a priority instead.